Multi-omics-based molecular classification of adrenocortical carcinoma predicts response to immunotherapy and targeted treatments
{{output}}
Adrenal cortical carcinoma (ACC) is a rare and highly aggressive malignant tumor with dismal outcomes. Once metastasis occurs, the 5-year survival rate falls below 15%. Current treatment options offer LIMited benefit for advanced disease, Largely due to the ab... ...
